The choice of the antigen in the dendritic cell-based vaccine therapy for prostate cancer
/in Dendritic Cells, International Publications, Prostate CancerComparison of monocyte-derived dendritic cells from colorectal cancer patients, non-small-cell-lung-cancer patients and healthy donors
/in Dendritic Cells, International Publications[The case of tumor escape mechanism by changing their tumor-associated antigens]
/in Dendritic Cells, Gallbladder Cancer, International PublicationsHeat-shock protein vaccines as active immunotherapy against human gliomas
/in Dendritic Cells, Glioblastoma, Hyperthermia, International Publications[Dendritic cell vaccine for intrahepatic cholangio cellular carcinoma–a study of relationship between immuno-reaction and clinical outcome]
/in Dendritic Cells, Gallbladder Cancer, International PublicationsPartial T cell-depleted allogeneic stem cell transplantation following reduced-intensity conditioning creates a platform for immunotherapy with donor lymphocyte infusion and recipient dendritic cell vaccination in multiple myeloma
/in Dendritic Cells, International Publications, Multiple MyelomaImmunotherapy with dendritic cells pulsed by autologous dactinomycin-induced melanoma apoptotic bodies for patients with malignant melanoma
/in Dendritic Cells, International Publications, Malignant MelanomaImmunizing against breast cancer: a new swing for an old sword
/in Breast Cancer, Dendritic Cells, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer